EP1012333A4 - ISOLATION OF A NEW GENE p23 FROM THE SENESCENCE FACTOR - Google Patents
ISOLATION OF A NEW GENE p23 FROM THE SENESCENCE FACTORInfo
- Publication number
- EP1012333A4 EP1012333A4 EP98938406A EP98938406A EP1012333A4 EP 1012333 A4 EP1012333 A4 EP 1012333A4 EP 98938406 A EP98938406 A EP 98938406A EP 98938406 A EP98938406 A EP 98938406A EP 1012333 A4 EP1012333 A4 EP 1012333A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- isolation
- new gene
- senescence factor
- senescence
- factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000002955 isolation Methods 0.000 title 1
- 230000009758 senescence Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90887397A | 1997-08-08 | 1997-08-08 | |
| US908873 | 1997-08-08 | ||
| PCT/US1998/016343 WO1999007893A1 (en) | 1997-08-08 | 1998-08-05 | ISOLATION OF A NOVEL SENESCENCE-FACTOR GENE, p23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1012333A1 EP1012333A1 (en) | 2000-06-28 |
| EP1012333A4 true EP1012333A4 (en) | 2003-01-02 |
Family
ID=25426353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP98938406A Withdrawn EP1012333A4 (en) | 1997-08-08 | 1998-08-05 | ISOLATION OF A NEW GENE p23 FROM THE SENESCENCE FACTOR |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1012333A4 (en) |
| JP (1) | JP2001512698A (en) |
| KR (1) | KR20010022741A (en) |
| CN (1) | CN1270637A (en) |
| AU (1) | AU8693598A (en) |
| BR (1) | BR9811865A (en) |
| CA (1) | CA2296598A1 (en) |
| TR (1) | TR200000331T2 (en) |
| WO (1) | WO1999007893A1 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002024721A1 (en) * | 2000-09-20 | 2002-03-28 | Human Genome Sciences, Inc. | 21 human secreted proteins |
| ATE463566T1 (en) * | 2000-01-21 | 2010-04-15 | Polymun Scient Immunbio Forsch | TUMOR AND SENSENCE MARKERS |
| AU750296B2 (en) | 2000-06-23 | 2002-07-11 | F. Hoffmann-La Roche Ag | Antibodies against SEMP1, methods for their production and uses thereof |
| WO2002101075A2 (en) | 2001-06-13 | 2002-12-19 | Millennium Pharmaceuticals, Inc. | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| DK2789684T3 (en) | 2008-05-23 | 2017-02-20 | Siwa Corp | Methods and compositions for facilitating regeneration |
| US9649376B2 (en) | 2010-09-27 | 2017-05-16 | Siwa Corporation | Selective removal of age-modified cells for treatment of atherosclerosis |
| US8721571B2 (en) | 2010-11-22 | 2014-05-13 | Siwa Corporation | Selective removal of cells having accumulated agents |
| CN107001459B (en) | 2014-09-19 | 2021-11-23 | Siwa有限公司 | anti-AGE antibodies for the treatment of inflammatory and autoimmune disorders |
| US10358502B2 (en) | 2014-12-18 | 2019-07-23 | Siwa Corporation | Product and method for treating sarcopenia |
| US9993535B2 (en) | 2014-12-18 | 2018-06-12 | Siwa Corporation | Method and composition for treating sarcopenia |
| ES2912064T3 (en) | 2016-02-19 | 2022-05-24 | Siwa Corp | Method and composition for treating cancer, killing metastatic cancer cells, and preventing cancer metastasis using antibody to advanced glycation end products (AGEs) |
| WO2018191718A1 (en) | 2017-04-13 | 2018-10-18 | Siwa Corporation | Humanized monoclonal advanced glycation end-product antibody |
| KR20180133452A (en) | 2016-04-15 | 2018-12-14 | 시와 코퍼레이션 | Anti-aging antibodies to treat neurodegenerative diseases |
| JP2019518763A (en) | 2016-06-23 | 2019-07-04 | シワ コーポレーション | Vaccines for use in the treatment of various diseases and disorders |
| US10961321B1 (en) | 2017-01-06 | 2021-03-30 | Siwa Corporation | Methods and compositions for treating pain associated with inflammation |
| US10858449B1 (en) | 2017-01-06 | 2020-12-08 | Siwa Corporation | Methods and compositions for treating osteoarthritis |
| US10925937B1 (en) | 2017-01-06 | 2021-02-23 | Siwa Corporation | Vaccines for use in treating juvenile disorders associated with inflammation |
| US10995151B1 (en) | 2017-01-06 | 2021-05-04 | Siwa Corporation | Methods and compositions for treating disease-related cachexia |
| US11518801B1 (en) | 2017-12-22 | 2022-12-06 | Siwa Corporation | Methods and compositions for treating diabetes and diabetic complications |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996013610A2 (en) * | 1994-10-31 | 1996-05-09 | Geron Corporation | Methods and reagents for the identification and regulation of senescence-related genes |
| WO1999007850A1 (en) * | 1997-08-06 | 1999-02-18 | Millennium Biotherapeutics, Inc. | Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides |
| WO1999046281A2 (en) * | 1998-03-10 | 1999-09-16 | Genentech, Inc. | Novel polypeptides and nucleic acids encoding the same |
| WO2000000609A2 (en) * | 1998-06-29 | 2000-01-06 | Incyte Pharmaceuticals, Inc. | Molecules associated with apoptosis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5580726A (en) * | 1994-04-29 | 1996-12-03 | Geron Corporation | Method and Kit for enhanced differential display |
-
1998
- 1998-08-05 EP EP98938406A patent/EP1012333A4/en not_active Withdrawn
- 1998-08-05 KR KR1020007001338A patent/KR20010022741A/en not_active Withdrawn
- 1998-08-05 WO PCT/US1998/016343 patent/WO1999007893A1/en active Search and Examination
- 1998-08-05 BR BR9811865-0A patent/BR9811865A/en not_active Application Discontinuation
- 1998-08-05 CN CN98807887A patent/CN1270637A/en active Pending
- 1998-08-05 AU AU86935/98A patent/AU8693598A/en not_active Abandoned
- 1998-08-05 TR TR2000/00331T patent/TR200000331T2/en unknown
- 1998-08-05 CA CA002296598A patent/CA2296598A1/en not_active Abandoned
- 1998-08-05 JP JP2000506375A patent/JP2001512698A/en not_active Withdrawn
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996013610A2 (en) * | 1994-10-31 | 1996-05-09 | Geron Corporation | Methods and reagents for the identification and regulation of senescence-related genes |
| WO1999007850A1 (en) * | 1997-08-06 | 1999-02-18 | Millennium Biotherapeutics, Inc. | Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides |
| WO1999046281A2 (en) * | 1998-03-10 | 1999-09-16 | Genentech, Inc. | Novel polypeptides and nucleic acids encoding the same |
| WO2000000609A2 (en) * | 1998-06-29 | 2000-01-06 | Incyte Pharmaceuticals, Inc. | Molecules associated with apoptosis |
Non-Patent Citations (12)
| Title |
|---|
| DATABASE EMBL [online] 15 June 1999 (1999-06-15), "Human Tango-73 encoding cDNA", XP002217496, retrieved from EBI Database accession no. AAX19956 * |
| DATABASE EMBL [online] 15 June 1999 (1999-06-15), "Human Tango-73 protein", XP002217495, retrieved from EBI Database accession no. AAY04143 * |
| DATABASE EMBL [online] 5 May 2000 (2000-05-05), "cDNA encoding a human molecule associated with apoptosis 2 (MAPOP-2)", XP002217494, retrieved from EBI Database accession no. AAZ60459 * |
| DATABASE EMBL [online] 7 December 1999 (1999-12-07), "Human PRO944 nucleotide sequence", XP002217498, retrieved from EBI Database accession no. AAZ34118 * |
| DATABASE EMBL [online] 7 December 1999 (1999-12-07), "Human PRO944 protein sequence", XP002217497, retrieved from EBI Database accession no. AAY41726 * |
| DATABASE EMBLLEVANT [online] 5 May 2000 (2000-05-05), "A human molecule associated with apoptosis 2 (MAPOP-2)", XP002217493, retrieved from EBI Database accession no. AAY68679 * |
| FURUSE M ET AL: "CLAUDIN-1 AND -2: NOVEL INTEGRAL MEMBRANE PROTEINS LOCALIZING AT TIGHT JUNCTIONS WITH NO SEQUENCE SIMILARITY TO OCCLUDIN", JOURNAL OF CELL BIOLOGY, ROCKEFELLER UNIVERSITY PRESS, NEW YORK, US, US, vol. 141, no. 7, 29 June 1998 (1998-06-29), pages 1539 - 1550, XP001008152, ISSN: 0021-9525 * |
| JONASDOTTIR A. ET AL.: "Refinement of the dominant optic atrophy locus (OPA1) to a 1.4-cM interval on chromosome 3q28-3q29 within a 3-Mb YAC contig", ORIGINAL INVESTIGATION, vol. 99, 1997, pages 115 - 120, XP002217491 * |
| LINSKENS M H K ET AL: "CATALOGING ALTERED GENE EXPRESSION IN YOUNG AND SENESCENT CELLS USING ENHANCED DIFFERENTIAL DISPLAY", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 23, no. 16, 1995, pages 3244 - 3251, XP002047039, ISSN: 0305-1048 * |
| See also references of WO9907893A1 * |
| SMITH D. ET AL.: "Localization of 616 human chromosome 3-specific cosmids using a somatic cell hybrid deletion mapping panel", GENOMICS, vol. 11, September 1991 (1991-09-01), pages 179 - 187, XP001107125 * |
| SWISSHELM K ET AL: "SEMP1, a senescence-associated cDNA isolated from human mammary epithelial cells, is a member of an epithelial membrane protein superfamily", GENE, ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, NL, vol. 226, no. 2, 21 January 1999 (1999-01-21), pages 285 - 295, XP004155143, ISSN: 0378-1119 * |
Also Published As
| Publication number | Publication date |
|---|---|
| TR200000331T2 (en) | 2000-05-22 |
| AU8693598A (en) | 1999-03-01 |
| CA2296598A1 (en) | 1999-02-18 |
| EP1012333A1 (en) | 2000-06-28 |
| KR20010022741A (en) | 2001-03-26 |
| CN1270637A (en) | 2000-10-18 |
| JP2001512698A (en) | 2001-08-28 |
| BR9811865A (en) | 2000-08-15 |
| WO1999007893A1 (en) | 1999-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1012333A4 (en) | ISOLATION OF A NEW GENE p23 FROM THE SENESCENCE FACTOR | |
| PL340600A1 (en) | Many times substituted varieties of protease | |
| IL122477A (en) | Expandable aircraft section | |
| ID24757A (en) | PRODUCT DETERGENT OF GRAIN | |
| IL132452A0 (en) | Preparation of hydroxy urethanes | |
| GB9514435D0 (en) | Inhibition of gene expression | |
| IL133248A (en) | Fungicide mixtures of methoxycarbamates | |
| ZA9873B (en) | Shower partition | |
| EP0813874A4 (en) | Remedy for pancreatitis | |
| GB9602060D0 (en) | Combined shower | |
| ZA941093B (en) | Shower partition | |
| ZA963356B (en) | Novel uses of heptafluoropropane | |
| GB2322546B (en) | Shower trays | |
| SG64924A1 (en) | Inhibiting photodecompostion of 3-substituted-2- oxindoles | |
| GB9515854D0 (en) | Spider inhibitor | |
| GB9521173D0 (en) | Isolation of parasites | |
| TW367984U (en) | Slide assembling structure for pulling-door of bathroom | |
| TW355041U (en) | Improvement of three section faucet | |
| IT239251Y1 (en) | ENAMELLED ENAMELLING CABIN | |
| GB9703672D0 (en) | Inhibition of gene expression | |
| GB9703663D0 (en) | Inhibition of gene expression | |
| GB9706060D0 (en) | Inhibition of gene expression | |
| TW309934U (en) | Structure of cigarrette shelf | |
| TW361152U (en) | New design of combined shelves | |
| IT243309Y1 (en) | CONTAINER - EXHIBITOR FOR PLURALITY OF OBJECTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20000125 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20021113 |
|
| AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20030116 |